论文部分内容阅读
我院自1997年1月至1998年6月共收治急性脑梗塞患者158例,其中80例患者应用地奥奥利达(中科院成都地奥制药公司出品)联合甘露醇、脉络宁治疗,取得满意疗效,现报道如下。 1 资料和方法 1.1 病例选择和分组 脑梗塞158例,均为首次发病的住院患者,经神经系统检查及颅脑CT检查确诊为脑梗塞,按1986年全国第二次脑血管病学术会议所制定脑卒中患者神经功能缺损程度进行评分、分型。158例患者按先后次序,随机分为两组,治疗组80例,男53例,女27例;年龄:38～80岁;重型20例,中型35例,轻型25例;病程1天内25例,3天内42例,7天内13例。对照组78例,男52例,女26例;年龄:40～78岁;重型19例,中型36例,轻型23例;病程1天内24例,3天内40例,7天内14例。两组患者在年龄、性别、病情、病程、入院时的平均动脉压及血糖、血脂水平,既往病史评分、伴发病积分方面,都无显著差异。
Our hospital from January 1997 to June 1998 were treated 158 patients with acute cerebral infarction, of which 80 patients with the Austrian Austrian Leida (Chengdu Austrian Austrian pharmaceutical company produced) with mannitol, Mailuoning treatment and achieved satisfaction Efficacy, are reported below. 1 Materials and Methods 1.1 Case Selection and Grouping 158 cases of cerebral infarction, are the first incidence of hospitalized patients, the diagnosis of cerebral infarction by neurological examination and brain CT examination, according to the 1986 National Cerebral Vascular Disease Conference Stroke patients with neurological deficits score, type. 158 patients were randomly divided into two groups, the treatment group 80 cases, 53 males and 27 females; aged 38 to 80 years; 20 cases of heavy, 35 cases of medium, 25 cases of light; course of disease within 1 day 25 cases 42 cases in 3 days and 13 cases in 7 days. Control group of 78 patients, 52 males and 26 females; age: 40 to 78 years old; heavy in 19 cases, 36 cases of medium and light in 23 cases; course of disease within 24 days in 1 day, 40 cases within 3 days, 7 cases within 14 days. There was no significant difference between the two groups in terms of age, sex, disease, course of disease, mean arterial pressure at hospital admission, blood glucose, blood lipid level, past medical history score and associated disease score.